Balaji and colleagues examined the expression level of the ABCC1 and ABCC3 genes in breast cancer patients (without division into molecular subtypes) and assessed their role in inducing the phenomenon of resistance to anticancer drugs. This evidence concerns the gene ABCC1 and breast carcinoma.